OpenURL Connection Search

Select item for more details and to access through your institution.

Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection.
Published in:
Journal of Infectious Diseases, 1997, v. 176, n. 5, p. 777
By:
- Fraaij, P. L. A.;
- van der Vries, E.;
- Beersma, M. F. C.;
- Riezebos-Brilman, A.;
- Niesters, H. G. M.;
- van der Eijk, A. A.;
- de Jong, M. D.;
- Reis Miranda, D.;
- Horrevorts, A. M.;
- Ridwan, B. U.;
- Wolfhagen, M. J. H. M.;
- Houmes, R. J.;
- van Dissel, J. T.;
- Fouchier, R. A. M.;
- Kroes, A. C. M.;
- Koopmans, M. P.;
- Osterhaus, A. D. M. E.;
- Boucher, C. A. B
Publication type:
Article
High-Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1-Infected Persons Does Not Result in Sustained Suppression of Viral Replication.
Published in:
Journal of Infectious Diseases, 1997, v. 175, n. 4, p. 966
By:
- Jong, M. D. de;
- Vella, S.;
- Carr, A.;
- Boucher, C. A. B.;
- Imrie, A.;
- French, M.;
- Hoy, J.;
- Sorice, S.;
- Pauluzzi, S.;
- Chiodo, F.;
- Weverling, G. J.;
- Ende, M. E. van der;
- Frissen, Ph. J.;
- Weigel, H. M.;
- Kauffmann, R. H.;
- Lange, J. M. A.;
- Yoon, R.;
- Moroni, M.;
- Hoenderdos, E.;
- Leitz, G.
Publication type:
Article
Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection.
Published in:
2011
By:
- Fraaij, P. L. A.;
- Vries, E. van der;
- Beersma, M. F. C.;
- Riezebos-Brilman, A.;
- Niesters, H. G. M.;
- Eijk, A. A. van der;
- Jong, M. D. de;
- Miranda, D. Reis;
- Horrevorts, A. M.;
- Ridwan, B. U.;
- Wolfhagen, M. J. H. M.;
- Houmes, R. J.;
- Dissel, J. T. van;
- Fouchier, R. A. M.;
- Kroes, A. C. M.;
- Koopmans, M. P.;
- Osterhaus, A. D. M. E.;
- Boucher, C. A. B.
Publication type:
Abstract
HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.
Published in:
Journal of Internal Medicine, 2011, v. 270, n. 6, p. 532, doi. 10.1111/j.1365-2796.2011.02456.x
By:
- Nichols, B. E.;
- Boucher, C. A. B.;
- van de Vijver, D. A. M. C.
Publication type:
Article
Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy.
Published in:
HIV Medicine, 2005, v. 6, n. 5, p. 299, doi. 10.1111/j.1468-1293.2005.00304.x
By:
- van den Berg, J. B.;
- Hak, E.;
- Vervoort, S. C. J. M.;
- Hoepelman, I. M.;
- Boucher, C. A. B.;
- Schuurman, R.;
- Schneider, M. M. E.
Publication type:
Article
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1850, doi. 10.1093/jac/dkv033
By:
- Swartz, J. E.;
- Vandekerckhove, L.;
- Ammerlaan, H.;
- de Vries, A. C.;
- Begovac, J.;
- Bierman, W. F. W.;
- Boucher, C. A. B.;
- van der Ende, M. E.;
- Grossman, Z.;
- Kaiser, R.;
- Levy, I.;
- Mudrikova, T.;
- Paredes, R.;
- Perez-Bercoff, D.;
- Pronk, M.;
- Richter, C.;
- Schmit, J. C.;
- Vercauteren, J.;
- Zazzi, M.;
- Lepej, S. Židovec
Publication type:
Article

Found: 6

Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection.

High-Dose Nevirapine in Previously Untreated Human Immunodeficiency Virus Type 1-Infected Persons Does Not Result in Sustained Suppression of Viral Replication.

Evaluation of the Antiviral Response to Zanamivir Administered Intravenously for Treatment of Critically Ill Patients With Pandemic Influenza A (H1N1) Infection.

HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance.

Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy.

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.